Please Enable Cookies to Continue
Please enable cookies in your browser to experience all the personalized features of this site, including the ability to apply for a job.
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development (R&D) organization that develops and delivers new treatments for neglected diseases affecting millions of the world’s poorest people.
Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people. Driven by collaboration, not competition, and by patients’ needs, not profits, we promote equitable access, foster inclusive and sustainable solutions, and advocate for a more effective global biomedical R&D system that meets the needs of neglected patients.
DNDi has delivered 14 new treatments for people with sleeping sickness, visceral leishmaniasis, Chagas disease, HIV, hepatitis C, and malaria that have saved millions of lives. We aim to deliver a total of 25 new treatments by 2028– addressing R&D gaps for neglected tropical diseases and viral infections, including new pandemic-prone diseases (such as COVID-19) and climate-sensitive diseases (such as dengue) with a focus on the needs of patients in low- and middle-income countries.
With more than 240 employees of 30+ nationalities located in nine offices on four continents, DNDi is committed to diversity, equity, and inclusion as essential parts of our culture and key drivers of our success. We encourage candidates of diverse profiles and backgrounds to apply.
The system cannot access your location for 1 of 2 reasons:
- Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
- Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort
-
The External Relations Officer supports DNDi’s fundraising efforts by carrying out prospect research, developing grant proposals, managing donor reporting, and supporting daytoday grant management., including institutional, public and private funding. Working closely with the External Relations Manager (ERM) and the global External Relations team, the Officer plays an active role in helping secure and steward resources essential to DNDi’s mission.
Approximately 60% of the role is dedicated...
-
The objective of this assignment is to strengthen the IST team in its capacity to deliver projects and to analyze business needs across financial solutions (eg EPM,ERP), data management, reporting, or AI-related initiatives.The Consultant will lead key cross-functional initiatives across departments and teams to improve system performance, enhance data availability, and drive overall organizational efficiency across DNDi and GARDP.
-
The Dengue program was initiated in 2022 and DNDi is partnering with dengue-endemic countries to find a safe, affordable, and effective treatment for dengue. Through these global collaborations, the activities will encompass joint projects to advance the pre-clinical development of new drug candidates and conduct clinical trials to test the most promising ones.
The Dengue Programme Leader plays a pivotal role in driving the scientific and strategic development of the programme. The incumbent supports the Head of Dengue Global Programme in overseeing preclinical and clinical activities at both global and regional levels, ensuring alignment with...
-
We are now seeking a senior, visionary Regulatory Sciences Lead to further strengthen strategic regulatory leadership across both organizations’ R&D portfolios. The overall purpose of this role is to provide visionary leadership in regulatory sciences across the joint DNDi–MMV platform, shaping innovative and globally aligned regulatory strategies that accelerate the development, approval, and equitable access to life-saving medicines for populations affected by neglected diseases.
